{"entity":{"type":"insider","cik":"0001848718","url":"/insider/0001848718","json_url":"/insider/0001848718.json","name":"Brown Ryan Edward","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":2,"first":"2024-03-05","last":"2024-06-25","span_basis":"filed_date"},"name_variants":[{"name":"Brown Ryan Edward","source":"filing","n_filings":2,"first_seen":"2024-03-05","last_seen":"2024-06-25"}],"transactions":[{"id":3021028,"accession":"0000950170-24-077522","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950170-24-077522","line_url":"/filing/0000950170-24-077522#line-10","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17581.0,"shares_display":"17,581","price_per_share":162.65,"price_display":"162.65","price_state":"stated","total_value":2859549.65,"total_display":"2,859,549.65","shares_owned_after":23518.0,"shares_owned_after_display":"23,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":3021025,"accession":"0000950170-24-077522","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-24-077522","line_url":"/filing/0000950170-24-077522#line-9","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7644.0,"shares_display":"7,644","price_per_share":158.07,"price_display":"158.07","price_state":"stated","total_value":1208287.08,"total_display":"1,208,287.08","shares_owned_after":48442.0,"shares_owned_after_display":"48,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":3021023,"accession":"0000950170-24-077522","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-077522","line_url":"/filing/0000950170-24-077522#line-8","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4168.0,"shares_display":"4,168","price_per_share":161.82,"price_display":"161.82","price_state":"stated","total_value":674465.76,"total_display":"674,465.76","shares_owned_after":41099.0,"shares_owned_after_display":"41,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":3021017,"accession":"0000950170-24-077522","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-24-077522","line_url":"/filing/0000950170-24-077522#line-7","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3840.0,"shares_display":"3,840","price_per_share":163.53,"price_display":"163.53","price_state":"stated","total_value":627955.2,"total_display":"627,955.20","shares_owned_after":19678.0,"shares_owned_after_display":"19,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":3021015,"accession":"0000950170-24-077522","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-077522","line_url":"/filing/0000950170-24-077522#line-6","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2549.0,"shares_display":"2,549","price_per_share":164.52,"price_display":"164.52","price_state":"stated","total_value":419361.48,"total_display":"419,361.48","shares_owned_after":17129.0,"shares_owned_after_display":"17,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":3021012,"accession":"0000950170-24-077522","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-077522","line_url":"/filing/0000950170-24-077522#line-5","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":159.14,"price_display":"159.14","price_state":"stated","total_value":350108.0,"total_display":"350,108.00","shares_owned_after":46242.0,"shares_owned_after_display":"46,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":3021010,"accession":"0000950170-24-077522","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-077522","line_url":"/filing/0000950170-24-077522#line-4","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":160.31,"price_display":"160.31","price_state":"stated","total_value":156302.25,"total_display":"156,302.25","shares_owned_after":45267.0,"shares_owned_after_display":"45,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-25","scope":"insider"},{"id":2734983,"accession":"0000950170-24-026609","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-026609","line_url":"/filing/0000950170-24-026609#line-3","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001848718","owner_name":"Brown Ryan Edward","owner_url":"/insider/0001848718","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":125.34,"price_display":"125.34","price_state":"stated","total_value":250680.0,"total_display":"250,680.00","shares_owned_after":31827.0,"shares_owned_after_display":"31,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Officer (EVP, General Counsel)","n_filings":2,"first_seen":"2024-03-05","last_seen":"2024-06-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001848718","retrieved_at":"2026-08-21T03:00:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}